|
1
|
Geng S, Gu L, Ju F, Zhang H, Wang Y, Tang
H, Bi Z and Yang C: MicroRNA-224 promotes the sensitivity of
osteosarcoma cells to cisplatin by targeting Rac1. J Cell Mol Med.
20:1611–1619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang M, Wang D, Zhu T and Yin R:
miR-214-5p targets ROCK1 and suppresses proliferation and invasion
of human osteosarcoma cells. Oncol Res. 25:75–81. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang Z, Zhang M, Chen Q and Zhang Q:
Downregulation of microRNA-145 promotes epithelial-mesenchymal
transition via regulating Snail in osteosarcoma. Cancer Gene Ther.
24:83–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen B, Huang Z, Zhang Y, Chen Y and Li Z:
MicroRNA-145 suppresses osteosarcoma metastasis via targeting
MMP16. Cell Physiol Biochem. 37:2183–2193. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu W, Dang S, Feng Q, Liang J, Wang Y and
Fan N: MicroRNA-542-3p inhibits the growth of hepatocellular
carcinoma cells by targeting FZD7/Wnt signaling pathway. Biochem
Biophys Res Commun. 482:100–105. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tormo E, Adam-Artigues A, Ballester S,
Pineda B, Zazo S, González-Alonso P, Albanell J, Rovira A, Rojo F,
Lluch A and Eroles P: The role of miR-26a and miR-30b in
HER2+ breast cancer trastuzumab resistance and
regulation of the CCNE2 gene. Sci Rep. 7:413092017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang T, Zhao P, Rong Z, Li B, Xue H, You
J, He C, Li W, He X, Lee RJ, et al: Anti-tumor efficiency of
lipid-coated cisplatin nanoparticles co-loaded with MicroRNA-375.
Theranostics. 6:142–154. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng JF, Ma XQ, Wang LP and Wang W:
MicroRNA-145 exerts tumor-suppressive and chemo-resistance lowering
effects by targeting CD44 in gastric cancer. World J Gastroenterol.
23:2337–2345. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wei R, Yang Q, Han B, Li Y, Yao K, Yang X,
Chen Z, Yang S, Zhou J, Li M, et al: microRNA-375 inhibits
colorectal cancer cells proliferation by downregulating JAK2/STAT3
and MAP3K8/ERK signaling pathways. Oncotarget. 8:16633–16641.
2017.PubMed/NCBI
|
|
12
|
Miao Y, Zheng W, Li N, Su Z, Zhao L, Zhou
H and Jia L: MicroRNA-130b targets PTEN to mediate drug resistance
and proliferation of breast cancer cells via the PI3K/Akt signaling
pathway. Sci Rep. 7:419422017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yan X, Zhu Z, Xu S, Yang LN, Liao XH,
Zheng M, Yang D, Wang J, Chen D, Wang L, et al: MicroRNA-140-5p
inhibits hepatocellular carcinoma by directly targeting the unique
isomerase Pin1 to block multiple cancer-driving pathways. Sci Rep.
7:459152017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li B, Zhang S, Shen H and Li C:
MicroRNA-144-3p suppresses gastric cancer progression by inhibiting
epithelial-to-mesenchymal transition through targeting PBX3.
Biochem Biophys Res Commun. 484:241–247. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feng S, Cong S, Zhang X, Bao X, Wang W, Li
H, Wang Z, Wang G, Xu J, Du B, et al: MicroRNA-192 targeting
retinoblastoma 1 inhibits cell proliferation and induces cell
apoptosis in lung cancer cells. Nucleic Acids Res. 39:6669–6678.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lian J, Jing Y, Dong Q, Huan L, Chen D,
Bao C, Wang Q, Zhao F, Li J, Yao M, et al: miR-192, a prognostic
indicator, targets the SLC39A6/SNAIL pathway to reduce tumor
metastasis in human hepatocellular carcinoma. Oncotarget.
7:2672–2683. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Zhang S, Xu Y, Zhang Y, Guan H, Li
X, Li Y and Wang Y: Upregulation of miR-192 inhibits cell growth
and invasion and induces cell apoptosis by targeting TCF7 in human
osteosarcoma. Tumour Biol. 37:15211–15220. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grabbe C, Husnjak K and Dikic I: The
spatial and temporal organization of ubiquitin networks. Nat Rev
Mol Cell Biol. 12:295–307. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liang Q, Dexheimer TS, Zhang P, Rosenthal
AS, Villamil MA, You C, Zhang Q, Chen J, Ott CA, Sun H, et al: A
selective USP1-UAF1 inhibitor links deubiquitination to DNA damage
responses. Nat Chem Biol. 10:298–304. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sourisseau T, Helissey C, Lefebvre C,
Ponsonnailles F, Malka-Mahieu H, Olaussen KA, André F, Vagner S and
Soria JC: Translational regulation of the mRNA encoding the
ubiquitin peptidase USP1 involved in the DNA damage response as a
determinant of Cisplatin resistance. Cell Cycle. 15:295–302. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garcia-Santisteban I, Peters GJ,
Giovannetti E and Rodríguez JA: USP1 deubiquitinase: Cellular
functions, regulatory mechanisms and emerging potential as target
in cancer therapy. Mol Cancer. 12:912013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lee JK, Chang N, Yoon Y, Yang H, Cho H,
Kim E, Shin Y, Kang W, Oh YT, Mun GI, et al: USP1 targeting impedes
GBM growth by inhibiting stem cell maintenance and radioresistance.
Neuro-Oncol. 18:37–47. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu J, Zhu H, Zhong N, Jiang Z, Xu L, Deng
Y, Jiang Z, Wang H and Wang J: Gene silencing of USP1 by lentivirus
effectively inhibits proliferation and invasion of human
osteosarcoma cells. Int J Oncol. 49:2549–2557. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Williams SA, Maecker HL, French DM, Liu J,
Gregg A, Silverstein LB, Cao TC, Carano RA and Dixit VM: USP1
deubiquitinates ID proteins to preserve a mesenchymal stem cell
program in osteosarcoma. Cell. 146:918–930. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Enneking WF, Spanier SS and Goodman MA: A
system for the surgical staging of musculoskeletal sarcoma. Clin
Orthop Relat Res. 106–120. 1980.PubMed/NCBI
|
|
26
|
Zhang Z, Yu L, Dai G, Xia K, Liu G, Song
Q, Tao C, Gao T and Guo W: Telomerase reverse transcriptase
promotes chemoresistance by suppressing cisplatin-dependent
apoptosis in osteosarcoma cells. Sci Rep. 7:70702017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei CH, Wu G, Cai Q, Gao XC, Tong F, Zhou
R, Zhang RG, Dong JH, Hu Y and Dong XR: MicroRNA-330-3p promotes
cell invasion and metastasis in non-small cell lung cancer through
GRIA3 by activating MAPK/ERK signaling pathway. J Hematol Oncol.
10:1252017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mahati S, Xiao L, Yang Y, Mao R and Bao Y:
miR-29a suppresses growth and migration of hepatocellular carcinoma
by regulating CLDN1. Biochem Biophys Res Commun. 486:732–737. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xiao Q, Yang Y, An Q and Qi Y:
MicroRNA-100 suppresses human osteosarcoma cell proliferation and
chemo-resistance via ZNRF2. Oncotarget. 8:34678–34686. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang P, Tang WM, Zhang H, Li YQ, Peng Y,
Wang J, Liu GN, Huang XT, Zhao JJ, Li G, et al: MiR-646 inhibited
cell proliferation and EMT-induced metastasis by targeting FOXK1 in
gastric cancer. Br J Cancer. 117:525–534. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen LL, Zhang ZJ, Yi ZB and Li JJ:
MicroRNA-211-5p suppresses tumour cell proliferation, invasion,
migration and metastasis in triple-negative breast cancer by
directly targeting SETBP1. Br J Cancer. 117:78–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Guo X, Yu L, Zhang Z, Dai G, Gao T and Guo
W: miR-335 negatively regulates osteosarcoma stem cell-like
properties by targeting POU5F1. Cancer Cell Int. 17:292017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fromm B, Billipp T, Peck LE, Johansen M,
Tarver JE, King BL, Newcomb JM, Sempere LF, Flatmark K, Hovig E and
Peterson KJ: A uniform system for the annotation of vertebrate
microRNA genes and the evolution of the human microRNAome. Annu Rev
Genet. 49:213–242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Botla SK, Savant S, Jandaghi P, Bauer AS,
Mücke O, Moskalev EA, Neoptolemos JP, Costello E, Greenhalf W,
Scarpa A, et al: Early epigenetic downregulation of microRNA-192
expression promotes pancreatic cancer progression. Cancer Res.
76:4149–4159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Geng L, Chaudhuri A, Talmon G, Wisecarver
JL, Are C, Brattain M and Wang J: MicroRNA-192 suppresses liver
metastasis of colon cancer. Oncogene. 33:5332–5340. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pichiorri F, Suh SS, Rocci A, De Luca L,
Taccioli C, Santhanam R, Zhou W, Benson DM Jr, Hofmainster C, Alder
H, et al: Downregulation of p53-inducible microRNAs 192, 194, and
215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma
development. Cancer Cell. 30:349–351. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang SY, Choi SA, Lee JY, Park AK, Wang
KC, Phi JH, Koh EJ, Park WY, Park SH, Hwang DW, et al: miR-192
suppresses leptomeningeal dissemination of medulloblastoma by
modulating cell proliferation and anchoring through the regulation
of DHFR, integrins, and CD47. Oncotarget. 6:43712–43730. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun J, Fan Z, Lu S, Yang J, Hao T and Huo
Q: miR-192 suppresses the tumorigenicity of prostate cancer cells
by targeting and inhibiting nin one binding protein. Int J Mol Med.
37:485–492. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang Y, Jia LS, Yuan W, Wu Z, Wang HB, Xu
T, Sun JC, Cheng KF and Shi JG: Low miR-34a and miR-192 are
associated with unfavorable prognosis in patients suffering from
osteosarcoma. Am J Transl Res. 7:111–119. 2015.PubMed/NCBI
|
|
40
|
Das DS, Das A, Ray A, Song Y, Samur MK,
Munshi NC, Chauhan D and Anderson KC: Blockade of deubiquitylating
enzyme USP1 inhibits DNA repair and triggers apoptosis in multiple
myeloma cells. Clin Cancer Res. 23:4280–4289. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhiqiang Z, Qinghui Y, Yongqiang Z, Jian
Z, Xin Z, Haiying M and Yuepeng G: USP1 regulates AKT
phosphorylation by modulating the stability of PHLPP1 in lung
cancer cells. J Cancer Res Clin Oncol. 138:1231–1238. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cao Y, Yu L, Dai G, Zhang S, Zhang Z, Gao
T and Guo W: Cinobufagin induces apoptosis of osteosarcoma cells
through inactivation of Notch signaling. Eur J Pharmacol.
794:77–84. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yu L, Fan Z, Fang S, Yang J, Gao T, Simões
BM, Eyre R, Guo W and Clarke RB: Cisplatin selects for stem-like
cells in osteosarcoma by activating Notch signaling. Oncotarget.
7:33055–33068. 2016.PubMed/NCBI
|
